Trivest Advisors »

Summit Therapeutics shares owned by Trivest Advisors

Quarter-by-quarter ownership of Summit Therapeutics (SMMT) shares owned by Trivest Advisors from 13F filings

Historical chart of Trivest Advisors investment in Summit Therapeutics

Tip: Access up to 7 years of quarterly data

All positions including Summit Therapeutics held by Trivest Advisors consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Summit Therapeutics by Trivest Advisors

Quarter filed Position value Share count Share price at filing
2025-03-31 $907k 47k 19.29

More positions owned by Trivest Advisors

NVIDIA Corporation (NVDA)
Bloom Energy Corp- A Com Cl A (BE)
Microsoft Corporation (MSFT)
Alphabet Inc-cl A Cap Stk Cl A (GOOGL)
Alibaba Group Holding-sp Sponsored Ads (BABA)
Broadcom (AVGO)
Seagate Technology Holdings Ord Shs (STX)
Amazon (AMZN)
Oracle Corporation (ORCL)
Meta Platforms Cl A (META)
Sea Ltd- Sponsord Ads (SE)
Western Digital (WDC)
Robinhood Markets Inc - A Com Cl A (HOOD)
Futu Holdings Ltd- Spon Ads Cl A (FUTU)
Alphabet Inc-cl C Cap Stk Cl C (GOOG)

View all positions for Trivest Advisors

Top funds holding Summit Therapeutics

Baker Bros. Advisors
Vanguard Group
FMR
BlackRock
State Street Corporation
Geode Capital Management
Susquehanna International
Pictet Asset Management Holding SA
Citadel Advisors
UBS Group
Apeiron Capital
Nomura Holdings
Standard Life Aberdeen
Squarepoint Ops
Sofinnova Ventures

View all funds holding Summit Therapeutics